The effects of hip and knee trigger point dry needling on pain & disability of patients with knee arthrosis

The effects of hip and knee trigger point dry needling on pain, function and balance in patients with knee osteoarthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015020415932N9

Enrollment

Registered

2015-07-01

Start date

2015-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis. Primary gonarthrosis, bilateral

Interventions

Intervention 1: The control group will be treated by dry needling 3 sessions (3 days a week) for trigger points around hip and knee joint. After needling, the needle will be moved in different directi

Treatment - Other

Treatment - Drugs

The control group will be treated by dry needling 3 sessions (3 days a week) for trigger points around hip and knee joint. After needling, the needle will be moved in different directions to detect mu

The control group will not receive treatment.

Eligibility

Sex/Gender

All

Age

45 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients with moderate knee Osteoarthritis based on Kellgren scale(have knee pain Morning stiffness less than half an hour Crepitation in movement Radiologic signs of Osteoarthritis have at least one trigger point on muscles around hip and knee Age 45-70 Visual Analogue Scale 3-7 Literate Exclusion criteria: Extraction of joint fluid or Corticosteroid injection history of surgery in lower limb or spinal Systemic disease Acute arthritis Soft tissue involvement in Rheumatoid arthritis Acute knee Inflammation Neurologic disease( such as Epilepsy) Anticoagulant use( such as Aspirin) Blood diseases(such as Hemophilia) Acute Immune disease Phobia of needle Lymphedema Malignancies AIDS Hepatitis Heart valve problem Acute infection Cardiovascular disease Pregnancy Intact vestibular system

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: before treatment and seven days after last session. Method of measurement: Visual analog scale.;Function. Timepoint: before treatment and seven days after last session. Method of measurement: Koos Questionnaire.;Balance. Timepoint: Before treatment and seven days after last session. Method of measurement: Y Balance test.	—

Secondary

Measure	Time frame
Performance. Timepoint: before treatment and seven days after last session. Method of measurement: 40m fast paced walk test & timed up and go test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajmeh Abdolahian

Shiraz University of Medical Sciences

abdolahiannajmeh@yahoo.com+98 31 3441 5945

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026